PP

Pradip Parbhunath Singh Suryavanshi

Active Director Director DIN 09190531
DIN 09190531 First appointment Jun 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Pradip Parbhunath Singh Suryavanshi

Data last updated:

Pradip Parbhunath Singh Suryavanshi is a Director at Rig Pharma Private Limited (since 2021). The company operates in Chemicals.

DIN 09190531
Primary Designation Director
Industry Chemicals
First Appointment 01 Jun 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rig Pharma Private Limited U24100CT2021PTC011649
Director01 Jun 20212021Active

Board colleagues of Pradip Parbhunath Singh Suryavanshi

NameDINCompanyDesignation
Nisha Pradeep Singh09190532Rig Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Rig Pharma Private Limited
Premium access

Shareholding and investment profile for Pradip Parbhunath Singh Suryavanshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pradip Parbhunath Singh Suryavanshi

Pradip Parbhunath Singh Suryavanshi currently holds 1 directorship: Rig Pharma Private Limited (Director, since 01 Jun 2021).

Pradip Parbhunath Singh Suryavanshi was first appointed on 01 Jun 2021 as Director at Rig Pharma Private Limited.

The current boards of Pradip Parbhunath Singh Suryavanshi's companies include Nisha Pradeep Singh (Rig Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available